Advanced search
Publication Cover
OncoTargets and Therapy Volume 10, 2017 - Issue
Submit an article Journal homepage
58
Views
4
CrossRef citations to date
0
Altmetric
Original Research

Impact of prior therapies on everolimus activity: an exploratory analysis of RADIANT-4

Roberto Buzzoni1 IRCCS Foundation, National Institute of Tumors, Milan, ItalyCorrespondence[email protected]
,
Carlo Carnaghi2 Humanitas Clinical and Research Center, Rozzano, Italy
,
Jonathan Strosberg3 Moffitt Cancer Center, Tampa, FL, USA
,
Nicola Fazio4 European Institute of Oncology, Milan, Italy
,
Simron Singh5 Sunnybrook Health Sciences Centre, Toronto, ON, Canada
,
Fabian Herbst6 Novartis AG, Basel, Switzerland
,
Antonia Ridolfi7 Novartis Pharma S.A.S., Rueil-Malmaison, France
,
Marianne E Pavel8 Medizinische Klinik 1, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany
,
Edward M Wolin9 Montefiore Einstein Center for Cancer Care, Bronx, NY, USA
,
Juan W Valle10 Institute of Cancer Sciences, University of Manchester, The Christie Hospital, Manchester, UK
,
Do-Youn Oh11 Seoul National University Hospital, Seoul, Republic of Korea
,
James C Yao12 University of Texas M.D. Anderson Cancer Center, Houston, TX, USA
&
Rodney Pommier13 Oregon Health & Science University, Portland, OR, USA
 show all
Pages 5013-5030 | Published online: 16 Oct 2017

Citations (4)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Marta Peri & Nicola Fazio. (2020) Clinical Evaluation of Everolimus in the Treatment of Neuroendocrine Tumors of the Lung: Patient Selection and Special Considerations. A Systematic and Critical Review of the Literature. Lung Cancer: Targets and Therapy 11, pages 41-52.
Read now
Lingaku Lee, Tetsuhide Ito & Robert T. Jensen. (2018) Everolimus in the treatment of neuroendocrine tumors: efficacy, side-effects, resistance, and factors affecting its place in the treatment sequence. Expert Opinion on Pharmacotherapy 19:8, pages 909-928.
Read now

Articles from other publishers (2)

Asger S. Paludan-Müller, Perrine Créquit & Isabelle Boutron. (2021) Reporting of harms in oncological clinical study reports submitted to the European Medicines Agency compared to trial registries and publications—a methodological review. BMC Medicine 19:1.
Crossref
Catherine G. Tran, Scott K. Sherman & James R. Howe. (2021) The Landmark Series: Management of Small Bowel Neuroendocrine Tumors. Annals of Surgical Oncology 28:5, pages 2741-2751.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.